CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization: CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
Tax period: 2021-01-01 to 2021-12-31
Filed: 2022-10-10
IRS object ID: 202242839349300549
Schema version: 2021v4.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2022-10-10T16:19:54-05:00	ReturnTs
Tax Period End	2021-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	221478099	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	COHNREZNICK LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	7501 WISCONSIN AVENUE SUITE 400E	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20814	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2021-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	311667995	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF THE	BusinessNameLine1Txt
Business Name Line2	AMERICAN SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine2Txt

Field	Value	IRS element (for citing)
Business Name Control	CONQ	BusinessNameControlTxt
Phone	5714831700	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD SUITE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	LINDA A JENSEN	PersonNm
Person Title	EVP & CFO	PersonTitleTxt
Phone	5714831700	PhoneNum
Signature	2022-10-07	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	LINDA	PersonFirstNm
Person Last	JENSEN	PersonLastNm

Field	Value	IRS element (for citing)
SSN	999009999	SSN

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	LORI ROTHE YOKOBOSKY CPA	PreparerPersonNm
PTIN	P01273422	PTIN
Phone	3016529100	PhoneNum
Preparation	2022-10-05	PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	3	TrustedCustomerCd
Authentication Assurance Level	AAL1	AuthenticationAssuranceLevelCd
Identity Assurance Level	IAL1	IdentityAssuranceLevelCd

Field	Value	IRS element (for citing)
Tax	2021	TaxYr
Build TS	2022-09-23 18:48:47Z	BuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER & CONQUER CANCER FDTN	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Principal Officer	NANCY DALY MS MPH	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL RD STE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$26,396,758	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.CONQUER.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1999	FormationYr
Legal Domicile State	VA	LegalDomicileStateCd
Activity Or Mission	TO ACCELERATE BREAKTHROUGHS IN LIFESAVING RESEARCH AND EMPOWER PEOPLE EVERYWHERE TO CONQUER CANCER.	ActivityOrMissionDesc
Voting Members Governing Body	20	VotingMembersGoverningBodyCnt
Voting Members Independent	19	VotingMembersIndependentCnt
Total Employee	0	TotalEmployeeCnt
Total Volunteers	189	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$34,795,083	PYContributionsGrantsAmt
CY Contributions Grants	$21,747,229	CYContributionsGrantsAmt
PY Program Service Revenue	$622,500	PYProgramServiceRevenueAmt
CY Program Service Revenue	$312,459	CYProgramServiceRevenueAmt
PY Investment Income	-$2,363,054	PYInvestmentIncomeAmt
CY Investment Income	$2,617,495	CYInvestmentIncomeAmt
PY Other Revenue	-$11,891	PYOtherRevenueAmt
CY Other Revenue	-$35,881	CYOtherRevenueAmt
PY Total Revenue	$33,042,638	PYTotalRevenueAmt
CY Total Revenue	$24,641,302	CYTotalRevenueAmt
PY Grants And Similar Paid	$14,740,700	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$19,181,199	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$0	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$0	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$222,000	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$60,000	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$5,310,959	CYTotalFundraisingExpenseAmt
PY Other Expenses	$10,278,908	PYOtherExpensesAmt
CY Other Expenses	$9,164,357	CYOtherExpensesAmt
PY Total Expenses	$25,241,608	PYTotalExpensesAmt
CY Total Expenses	$28,405,556	CYTotalExpensesAmt
PY Revenues Less Expenses	$7,801,030	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$3,764,254	CYRevenuesLessExpensesAmt
Total Assets BOY	$107,923,414	TotalAssetsBOYAmt
Total Assets EOY	$109,850,269	TotalAssetsEOYAmt
Total Liabilities BOY	$9,249,329	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$10,347,798	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$98,674,085	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$99,502,471	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	CONQUER CANCER FUNDS RESEARCH FOR EVERY TYPE OF CANCER TO BENEFIT EVERY PATIENT, EVERYWHERE. WORKING IN COLLABORATION WITH A GLOBAL NETWORK OF TOP SCIENTISTS AND CLINICIANS, AND LEADING ADVOCACY AND RESEARCH ORGANIZATIONS, CONQUER CANCER DRAWS (CONTINUED IN SCHEDULE O) ON THE PASSION AND EXPERTISE OF THE CANCER PROFESSIONALS WHO ARE MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO). CONQUER CANCER WORKS TO HELP CREATE A WORLD WHERE CANCER IS PREVENTED OR CURED AND EVERY SURVIVOR IS HEALTHY.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$15,907,019	ExpenseAmt
Grant	$14,002,989	GrantAmt
Revenue	$312,459	RevenueAmt
Desc	RESEARCH: THE CONQUER CANCER GRANTS & AWARDS PROGRAM HAS BEEN RECOGNIZING EXCELLENCE IN CLINICAL RESEARCH, QUALITY CARE, AND TEACHING IN THE FIELD OF ONCOLOGY SINCE 1984, WHEN THE PROGRAM ORIGINALLY BEGAN UNDER THE PURVIEW OF ASCO. CONQUER CANCER HAS A DEMONSTRATED TRACK RECORD OF SUPPORTING THE EARLY CAREER DEVELOPMENT OF ONCOLOGY RESEARCHERS, INCLUDING IDENTIFYING AND NURTURING THOSE WHO HAVE BECOME NOTABLE LEADERS AND INNOVATORS IN THE FIELD. PAST GRANT RECIPIENTS HAVE BECOME HEADS OF LARGE CANCER INSTITUTIONS AND PRESIDENTS OF MAJOR ONCOLOGY SOCIETIES, AS WELL AS GUIDED THE NATIONAL ONCOLOGY CONVERSATION THROUGH SERVICE ON BOARDS AND COMMITTEES. ADDITIONALLY, PAST RECIPIENTS HAVE ALSO INVESTED IN THE NEXT GENERATION OF YOUNG INVESTIGATORS BY SERVING AS MENTORS TO NEWLY CHOSEN CONQUER CANCER GRANTEES. CONQUER CANCER FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. CONQUER CANCER AND ASCO HAVE FUNDED MORE THAN $146 MILLION IN CANCER RESEARCH GRANTS TO OVER 2,400 RECIPIENTS IN 78 COUNTRIES. HIGHLIGHTS OF 2021 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: ADVANCED CLINICAL RESEARCH AWARD (ACRA): $900,000 PROVIDED TWO (2) THREE-YEAR AWARDS TO SUPPORT PHYSICIAN-SCIENTISTS COMMITTED TO PERFORMING ORIGINAL, CLINICAL CANCER RESEARCH WITH A PATIENT-ORIENTED FOCUS, INCLUDING CLINICAL RESEARCH STUDIES AND/OR TRANSLATIONAL RESEARCH INVOLVING HUMAN SUBJECTS. ONE AWARD WAS TO SUPPORT DIVERSITY/INCLUSION, FOCUSING ON BREAST CANCER AND THE SECOND ON IMMUNE CHECKPOINT INHIBITOR THERAPY. CAREER DEVELOPMENT AWARD (CDA): $4,200,000 PROVIDED TWENTY-ONE (21) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS. YOUNG INVESTIGATOR AWARD (YIA): $4,700,000 PROVIDED NINETY-FOUR (94) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD: $250,000 PROVIDED FIVE (5) ONE-YEAR AWARDS TO EARLY-CAREER INVESTIGATORS CONDUCTING RESEARCH IN LOW RESOURCE SETTINGS ON SCIENTIFIC QUESTIONS SPECIFIC TO THOSE SETTINGS, WITH THE POTENTIAL TO OFFER "REVERSE INNOVATION" INSIGHTS TO INFLUENCE ONCOLOGY PRACTICE IN A WIDE RANGE OF RESOURCE SETTINGS, BY INVESTIGATORS IN HIGH RESOURCE SETTINGS ON ISSUES IN RESOURCE-LIMITED SETTINGS, OR COLLABORATIVE RESEARCH BETWEEN INVESTIGATORS IN BOTH HIGH AND LOW RESOURCE SETTINGS ON QUESTIONS OF SHARED CONCERN. THE GOAL FOR THE GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD IS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN GLOBAL ONCOLOGY, AND TO DEVELOP THE NEXT GENERATION OF RESEARCHERS TO ADDRESS GLOBAL HEALTH NEEDS. INTERNATIONAL INNOVATION GRANT: $260,000 PROVIDED THIRTEEN (13) ONE-YEAR AWARDS IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT CAN HAVE A SIGNIFICANT IMPACT ON CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES. THE INTERNATIONAL INNOVATION GRANT PROGRAM IS INTENDED TO SUPPORT PROPOSALS THAT HAVE THE POTENTIAL TO REDUCE THE CANCER BURDEN IN LOCAL COMMUNITIES, WHILE ALSO BEING POTENTIALLY TRANSFERRABLE TO OTHER LOW- OR MIDDLE- INCOME SETTINGS. GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP: $50,000 PROVIDED ONE (1) ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST CANCER AWARD RECIPIENT.THROUGH ITS EVERYGRANT PROGRAM, CONQUER CANCER COLLABORATES WITH OTHER ORGANIZATIONS TO DEVELOP AND DELIVER GRANTS PROGRAMS THAT MAKE A DIFFERENCE TO CANCER CARE TEAMS AND PATIENTS EVERYWHERE. CONQUER CANCER WORKS WITH ORGANIZATIONS TO DEVELOP GRANTS PROGRAMS THAT HAVE REAL IMPACT ON RESEARCHERS AND PATIENT CARE, INSTITUTE PEER REVIEW PROCESSES THAT ENSURE APPLICATIONS MEET THE HIGHEST STANDARDS, AND ESTABLISH PROCESSES THAT MAKE ADMINISTRATION OF RESEARCH GRANTS BOTH EFFECTIVE AND EFFICIENT.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$4,814,004	ExpenseAmt
Grant	$4,453,739	GrantAmt
Desc	PROFESSIONAL EDUCATION: CONQUER CANCER SUPPORTS THE EFFORTS OF ASCO TO PROVIDE EDUCATION PROGRAMS IN THE US AND INTERNATIONALLY WHICH PROMOTE THE VITAL EXCHANGE OF IDEAS AND LATEST DEVELOPMENTS THAT LEAD TO WORLD-CLASS CARE, EVERYWHERE. FUNDS FROM CONQUER CANCER ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THROUGH BOTH MEETINGS AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC PROGRAMS SUPPORTED BY CONQUER CANCER AND PRESENTED TO THE PUBLIC IN 2021 INCLUDE THE FOLLOWING: VIRTUAL ASCO ANNUAL MEETING: THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTED APPROXIMATELY 32,950 PARTICIPANTS WORLDWIDE IN 2021. THE ANNUAL MEETING PROVIDES A FORUM TO EXPLORE CUTTING EDGE SCIENCE AND EDUCATION ACROSS MULTIPLE DISCIPLINES AND FIELDS IN ONCOLOGY WHILE ADDRESSING THE NEED FOR EVERY PATIENT TO RECEIVE THE HIGHEST QUALITY AND EQUITABLE CANCER CARE AVAILABLE. GASTROINTESTINAL CANCERS (GI) SYMPOSIUM: THIS IS THE PREMIER MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING. THE GI SYMPOSIUM GIVES HEALTHCARE PROVIDERS ACROSS MULTIPLE DISCIPLINES AND PROFESSIONS THE OPPORTUNITY TO RECEIVE CRITICAL UPDATES AND RECOMMENDATIONS TO IMPROVE THE CARE OF PATIENTS WITH GI CANCERS.GENITOURINARY CANCERS (GU) SYMPOSIUM: THIS IS THE PREEMINENT GENITOURINARY ONCOLOGY EVENT, ADDRESSING THE MULTIDISCIPLINARY NEEDS OF PHYSICIANS AND OTHER MEMBERS OF THE CANCER CARE AND RESEARCH COMMUNITY WHO DIAGNOSE, TREAT, AND STUDY GENITOURINARY MALIGNANCIES. THE GU SYMPOSIUM PROVIDES THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. QUALITY CARE SYMPOSIUM: THIS IS AN UNPARALLELED OPPORTUNITY TO LEVERAGE THE MOST UP-TO-DATE SCIENCE AND DISCOVER PROVEN STRATEGIES AND TOOLS CRITICAL TO MAKING KEY DECISIONS THAT CAN REDUCE DISPARITIES IN CARE FOR EVERY PATIENT, EVERY DAY, EVERYWHERE. THE SYMPOSIUM BRINGS TOGETHER LEADERS IN THE FIELD TO SHARE STRATEGIES AND METHODS FOR MEASURING AND IMPROVING THE QUALITY OF CANCER CARE AND DISSEMINATES INFORMATION ON THE IMPROVEMENT OF THE QUALITY OF PATIENT AND SURVIVOR CARE.EDUCATION SCHOLARS PROGRAM (ESP): THIS PROGRAM IS A YEARLONG PROFESSIONAL DEVELOPMENT INITIATIVE, WHICH AIMS TO CREATE A COHORT OF ONCOLOGISTS WITH BOTH LEADERSHIP SKILLS AND EXPERTISE IN LEARNING SCIENCE AND EDUCATION DESIGN. THROUGH THIS PROGRAM, ESP PARTICIPANTS BECOME EXPERIENCED IN USING THE LATEST LEARNING SCIENCE TO MORE EFFECTIVELY PRESENT GROUND-BREAKING CANCER DEVELOPMENTS TO THE ONCOLOGY COMMUNITY TO ADVANCE CANCER RESEARCH AND IMPROVE PATIENT CARE. PARTICIPANTS IN THE EDUCATION SCHOLARS PROGRAM RECEIVE DIDACTIC AND HANDS-ON TRAINING BY LEARNING SCIENCE SCHOLARS ON HOW TO DESIGN EFFECTIVE EDUCATIONAL PROGRAMS FOR ADULT LEARNERS.MERIT AWARDS: $226,000 PROVIDED TWO HUNDRED TWENTY-ONE (221) MERIT AWARDS WHICH PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AT ASCO SCIENTIFIC MEETINGS AND DISEASE SPECIFIC SYMPOSIA. MEDICAL STUDENT ROTATION FOR UNDERREPRESENTED POPULATIONS (MSR): $221,000 PROVIDED TWENTY-SIX (26) MEDICAL STUDENT ROTATIONS. THE MSR PROVIDES A 4-WEEK CLINICAL OR CLINICAL RESEARCH ROTATION FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. A MENTORING COMPONENT IS INCLUDED IN THE MSR WHEREBY AWARD RECIPIENTS ARE PAIRED WITH A CLINICAL ONCOLOGIST WHO PROVIDES ACADEMIC AND CAREER GUIDANCE, BOTH DURING AND FOLLOWING THE ROTATION EXPERIENCE. ANNUAL MEETING RESEARCH AWARD (AMRA): $10,500 PROVIDED FOR SEVEN (7) ANNUAL MEETING RESEARCH AWARDS FOR THOSE UNDERREPRESENTED IN MEDICINE (UIM). IN ADDITION TO ATTENDING THE VIRTUAL ASCO ANNUAL MEETING, RECIPIENTS OF THE AMRA PARTICIPATED IN THE 2021 VIRTUAL ABSTRACT FORUM TO PRESENT THEIR ONCOLOGY-RELATED RESEARCH AND RECEIVE FEEDBACK ON THEIR PRESENTATION SKILLS AND WERE ALSO MATCHED WITH AN ONCOLOGIST-IN-TRAINING WHO SERVED AS A MENTOR DURING THE VIRTUAL ASCO ANNUAL MEETING. ADDITIONALLY, RECIPIENTS WERE ALSO ABLE TO PARTICIPATE IN THE 2021-22 DIVERSITY MENTORING PROGRAM, A 6- TO 12-MONTH MENTORSHIP PROGRAM DESIGNED TO ENCOURAGE UIM MEDICAL STUDENTS AND RESIDENTS TO PURSUE REWARDING CAREERS IN ONCOLOGY. THE PROGRAM SEEKS TO EDUCATE PHYSICIANS-IN-TRAINING ABOUT ONCOLOGY CAREERS BY FOSTERING RELATIONSHIPS WITH MENTORS WHO CAN PROVIDE CAREER AND EDUCATIONAL GUIDANCE AND SERVE AS A PROFESSIONAL RESOURCE. ADDITIONALLY, AMRA RECIPIENTS WERE INVITED TO PARTICIPATE IN THE ASCO VIRTUAL PROFESSIONAL DEVELOPMENT SESSIONS AND THE VIRTUAL GRANT WRITING WORKSHOP.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$569,240	ExpenseAmt
Grant	$523,801	GrantAmt
Desc	QUALITY & ACCESS TO CARE: REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CONQUER CANCER IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND EQUITABLE ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CONQUER CANCER IN 2021 INCLUDE THE FOLLOWING: COVID-19 IMPACTS CANCER INITIATIVE : THE IMPACT OF COVID-19 ON CANCER CARE CONTINUED INTO 2021 AND CONQUER CANCER CONTINUED ITS WORK IN REPONDING TO THIS CRISIS THROUGH ITS SUPPORT OF THE FOLLOWING ACTIVITIES: -ASCO SURVEY ON COVID-19 IN ONCOLOGY REGISTRY (ASCO REGISTRY)- TO HELP THE ONCOLOGY COMMUNITY LEARN ABOUT THE PATTERN OF SYMPTOMS AND SEVERITY OF COVID-19 AMONG PATIENTS WITH CANCER AND HOW INFECTIONS IMPACT THE DELIVERY OF CANCER CARE AND PATIENT OUTCOMES, CONQUER CANCER'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), PROVIDED THE MEANS FOR THE ONCOLOGY COMMUNITY TO SUBMIT DATA ABOUT CANCER PATIENTS WITH COVID-19. DATA WAS MADE AVAILABEL TO THE PUBLIC ON ASCO'S WEBSITE THROUGH A REGISTRY DATA DASHBOARD AND REGISTRY DATA MAP. GRANTS WERE ALSO ISSUED TO SUPPORT THE RAPID ANALYSIS OF REGISTRY DATA, MANUSCRIPT DEVELOPMENT, AND DISSEMINATION OF FINDINGS INTO HIGH-IMPACT SCIENTIFIC, PEER-REVIEWED MANUSCRIPTS SO THOSE WHO TREAT CANCER PATIENTS WERE ABLE TO RECIVE VITAL INFORMATION ON HOW THE PANDEMIC CONTINUES TO IMPACT PATIENTS WITH CANCER. -MEASURE DEVELOPMENT- UNDERSTANDING THE IMPACT COVID-19 HAD ON PEOPLE WITH CANCER REQUIRES ANALYSIS OF CARE DELIVERY AND OUTCOMES, WHICH REQUIRES QUALITY MEASURES. THIS WORK PROVIDED A BETTER UNDERSTANDING OF HOW THE PANDEMIC AFFECTED SAFETY, EQUITY AND TIMELINESS OF CANCER CARE TO GUIDE CHANGES FOR THE FUTURE TO ENSURE QUALITY CARE FOR ALL PEOPLE WITH CANCER.-EDUCATIONAL RESOURCES FOR PATIENTS WITH CANCER AND CANCER SURVIVORS - REGULARLY UPDATED INFORMATION IN ENGLISH AND SPANISH ABOUT COVID-19 WAS PROVIDED FOR PEOPLE WITH CANCER AND CANCER SURVIVORS THROUGH ASCO'S PATIENT INFORMATION WEBSITE, CANCER.NET. -EDUCATION FOR CANCER CARE PROVIDERS - REGULARLY UPDATED INFORMATION ON TREATMENT OF PATIENTS WITH COVID-19 WAS PROVIDED TO SUPPORT CLINICIANS, THE CANCER CARE DELIVERY TEAM, AND PATIENTS WITH CANCER. EQUITY, DIVERSITY AND INCLUSION: ASSURING HIGH-QUALITY AND EQUITABLE CARE FOR EVERY PATIENT WITH CANCER HAS BEEN AT THE CORE OF THE THREE MISSION PILLARS (RESEARCH, EDUCATION, AND QUALITY) OF ASCO AND CONQUER CANCER. BOTH ORGANIZATIONS HAVE ALWAYS SOUGHT TO ADDRESS DISPARITIES AND INEQUITIES IN CARE EXPERIENCED BY MARGINALIZED POPULATIONS AND THE LACK OF DIVERSITY IN THE ONCOLOGY WORKFORCE. WHILE THE COMMITMENT TO ADDRESS THESE GAPS IN CARE IS LONGSTANDING, BOTH ASCO AND CONQUER CANCER HAVE SIGNIFICANTLY EXPANDED THEIR EQUITY, DIVERSITY, AND INCLUSION PROGRAMS TO ACHIEVE THREE OVERARCHING GOALS: -MAKE CLINICAL TRIALS MORE ACCURATELY REPRESENT THE POPULATION OF PATIENTS WITH CANCER AND ENSURE THAT THEY ARE ROUTINELY OFFERED AS A TREATMENT OPTION, WITH ALL PATIENTS HAVING EQUITABLE ACCESS. -MAKE THE ONCOLOGY WORKFORCE BETTER REFLECTS THE DIVERSITY OF THE POPULATION AND ENSURE THAT IT IS WELL-EQUIPPED TO DELIVER HIGH-QUALITY, EQUITABLE CARE FOR EVERY PATIENT. -DECREASE THE NUMBER OF BARRIERS TO ACCESSING CANCER CARE BY ENSURING THAT ONCOLOGY PRACTICES HAVE THE RESOURCES NEEDED TO ADVOCATE FOR PATIENTS AND TO SUSTAINABLY DELIVER HIGH-QUALITY, EQUITABLE CARE TO ALL PATIENTS.*QUALITY TRAINING PROGRAM: CONQUER CANCER SUPPORTS ASCO'S QUALITY TRAINING PROGRAM, WHICH EMPOWERS PRACTICE TEAMS TO IMPROVE CLINICAL CARE AND OPERATIONAL PERFORMANCE BY TEACHING TEAMS HOW TO BALANCE QUALITY IMPROVEMENT PROJECTS WITH DEMANDING SCHEDULES AND COMPETING PRIORITIES. WINTER AND SUMMER SESSIONS PROVIDED VIRTUAL CONTENT SPECIFICALLY FOR ONCOLOGY PRACTICE TEAMS AND INCLUDED ACCESS TO RENOWNED FACULTY AND COACHES DURING FIVE FOCUSED DAYS OF LEARNING.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$215,853	ExpenseAmt
Grant	$200,670	GrantAmt
Desc	PATIENT EDUCATION AND INFORMATION: CONQUER CANCER SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CONQUER CANCER TO CONTINUE AND EXPAND ITS WORK TO INFORM PATIENTS. A HIGHLIGHT OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CONQUER CANCER IN 2021 IS: *CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS. ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 120 TYPES OF CANCER AND SYNDROMES. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$215,853	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$200,670	TotalOtherProgSrvcGrantAmt
Total Program Service Expenses	$21,506,116	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	0	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (1)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	0	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	0	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (1)	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	230	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	0	EmployeeCnt
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	20	GoverningBodyVotingMembersCnt
Independent Voting Member	19	IndependentVotingMemberCnt
Family Or Business Rln	Yes (1)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	Yes (1)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (1)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	0	CompensationProcessCEOInd
Compensation Process Other	0	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	LINDA JENSEN EVP CFO	PersonNm
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD STE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (22 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt
CLIFFORD HUDIS MD FACP FASCO
CHIEF EXECUTIVE OFFICER	6.50	31.00	Yes (X)	Yes (X)	$0	$888,725	$21,750
HOWARD BURRIS III MD FACP FASC
CHAIR	2.00		Yes (X)	Yes (X)	$0	$0	$0
SANDRA SWAIN MD FACP FASCO
SECRETARY	1.00		Yes (X)	Yes (X)	$0	$0	$0
ALEXANDER W CASDIN
TREASURER	1.00		Yes (X)	Yes (X)	$0	$0	$0
KATHRYN BEAL MD
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
RICHARD BOXER MD FACS
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
RICCARDO BRAGLIA
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
SUSAN L COHN MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
LAWRENCE H EINHORN MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
RAJ MANTENA RPH
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
THOMAS A MARSLAND MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
ROBERT J MAYER MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
GERALD J MCDOUGALL
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
ANNE MOORE MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
W CHARLES PENLEY MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
AMY C PETERSON MD
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
THOMAS G ROBERTS JR MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
STEVEN T ROSEN MD FACP FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
MARGARET A TEMPERO MD FASCO
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
DEANNA B VAN GESTEL
BOARD MEMBER	1.00		Yes (X)		$0	$0	$0
LINDA JENSEN CPA
CFO & EXECUTIVE VP	1.00	36.50		Yes (X)	$0	$413,551	$42,559
NANCY DALY MS MPH
CEO & EXECUTIVE VP	36.50	1.00		Yes (X)	$0	$415,557	$46,187

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$0	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$1,717,833	TotReportableCompRltdOrgAmt
Total Other Compensation	$110,496	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	0	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
TRUE NORTH INC
12 WEST 27TH STREET 13TH FLOOR	NEW YORK	NY	10001	DIRECT MAIL SOLICITATIONS	$1,193,780
FAIRCOM NY
630 3RD AVENUE 12TH FLOOR	NEW YORK	NY	10017	DIRECT MAIL SOLICITATIONS	$653,743

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	2	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$6,418	FederatedCampaignsAmt
Membership Dues	$95,000	MembershipDuesAmt
Fundraising	$1,806,035	FundraisingAmt
Related Organizations	$3,566,050	RelatedOrganizationsAmt
All Other Contributions	$16,273,726	AllOtherContributionsAmt
Noncash Contributions	$82,417	NoncashContributionsAmt
Total Contributions	$21,747,229	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	GRANTS EXPERTISE	Desc
Business	900009	BusinessCd
Total Revenue Column	$312,459	TotalRevenueColumnAmt
Related Or Exempt Func Income	$312,459	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$312,459	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,980,450	TotalRevenueColumnAmt
Exclusion	$1,980,450	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$2,356,620	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$1,719,575	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$637,045	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$637,045	TotalRevenueColumnAmt
Exclusion	$637,045	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$0	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$1,806,035	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$35,881	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$35,881	TotalRevenueColumnAmt
Exclusion	-$35,881	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$24,641,302	TotalRevenueColumnAmt
Related Or Exempt Func Income	$312,459	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$2,581,614	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$17,692,699	TotalAmt
Program Services	$17,692,699	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$385,500	TotalAmt
Program Services	$385,500	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$1,103,000	TotalAmt
Program Services	$1,103,000	ProgramServicesAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$5,963,492	TotalAmt
Program Services	$1,799,875	ProgramServicesAmt
Management And General	$1,048,700	ManagementAndGeneralAmt
Fundraising	$3,114,917	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$34,369	TotalAmt
Management And General	$34,369	ManagementAndGeneralAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$60,000	TotalAmt
Fundraising	$60,000	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$35,258	TotalAmt
Management And General	$35,258	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$1,082,357	TotalAmt
Program Services	$239,987	ProgramServicesAmt
Management And General	$232,111	ManagementAndGeneralAmt
Fundraising	$610,259	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$46,138	TotalAmt
Fundraising	$46,138	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$561,540	TotalAmt
Program Services	$29,068	ProgramServicesAmt
Management And General	$25,763	ManagementAndGeneralAmt
Fundraising	$506,709	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$727,824	TotalAmt
Program Services	$3,405	ProgramServicesAmt
Management And General	$4,566	ManagementAndGeneralAmt
Fundraising	$719,853	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$540,312	TotalAmt
Program Services	$188,622	ProgramServicesAmt
Management And General	$165,597	ManagementAndGeneralAmt
Fundraising	$186,093	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$47,149	TotalAmt
Program Services	$26,415	ProgramServicesAmt
Management And General	$3,849	ManagementAndGeneralAmt
Fundraising	$16,885	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$120,732	TotalAmt
Program Services	$37,545	ProgramServicesAmt
Management And General	$38,268	ManagementAndGeneralAmt
Fundraising	$44,919	FundraisingAmt

Other Expenses OtherExpensesGrp

Field	Value	IRS element (for citing)
Desc	UBI TAX	Desc
Total	$5,186	TotalAmt
Fundraising	$5,186	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$28,405,556	TotalAmt
Program Services	$21,506,116	ProgramServicesAmt
Management And General	$1,588,481	ManagementAndGeneralAmt
Fundraising	$5,310,959	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$12,722,183	BOYAmt
EOY	$5,062,629	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$5,286,368	BOYAmt
EOY	$5,040,333	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$246,172	BOYAmt
EOY	$164,928	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$89,668,691	BOYAmt
EOY	$99,582,379	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$107,923,414	BOYAmt
EOY	$109,850,269	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$173,364	BOYAmt
EOY	$401,810	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$5,890,831	BOYAmt
EOY	$4,926,484	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$2,173,918	BOYAmt
EOY	$3,600,008	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$1,011,216	BOYAmt
EOY	$1,419,496	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$9,249,329	BOYAmt
EOY	$10,347,798	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$42,169,176	BOYAmt
EOY	$47,032,655	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$56,504,909	BOYAmt
EOY	$52,469,816	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$98,674,085	BOYAmt
EOY	$99,502,471	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$107,923,414	BOYAmt
EOY	$109,850,269	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	-$3,764,254	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$4,592,640	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Info In Schedule O Part XII	Yes (X)	InfoInScheduleOPartXIIInd
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consol And Sep Basis Fincl Stmt	Yes (X)	ConsolAndSepBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$29,032,906	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$31,998,377	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$27,209,762	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$34,945,083	CurrentTaxYearMinus1YearAmt
Current Tax Year	$22,059,688	CurrentTaxYearAmt
Total	$145,245,816	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$29,032,906	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$31,998,377	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$27,209,762	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$34,945,083	CurrentTaxYearMinus1YearAmt
Current Tax Year	$22,059,688	CurrentTaxYearAmt
Total	$145,245,816	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$19,658,904	SubstantialContributorsTotAmt
Public Support Total170	$125,586,912	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$908,055	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$719,934	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$2,667,684	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,592,952	CurrentTaxYearMinus1YearAmt
Current Tax Year	$1,980,450	CurrentTaxYearAmt
Total	$7,869,075	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus2 Years	$269,300	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$276,883	CurrentTaxYearMinus1YearAmt
Total	$546,183	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$153,661,074	TotalSupportAmt
Public Support CY170	0.81730	PublicSupportCY170Pct
Public Support PY170	0.67450	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$35,692,561	BeginningYearBalanceAmt
Contributions	$1,997,125	ContributionsAmt
Investment Earnings Or Losses	$2,783,059	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,394,375	GrantsOrScholarshipsAmt
End Year Balance	$39,078,370	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$27,740,161	BeginningYearBalanceAmt
Contributions	$6,504,115	ContributionsAmt
Investment Earnings Or Losses	$2,786,765	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,338,480	GrantsOrScholarshipsAmt
End Year Balance	$35,692,561	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$17,571,755	BeginningYearBalanceAmt
Contributions	$8,235,901	ContributionsAmt
Investment Earnings Or Losses	$2,772,005	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$839,500	GrantsOrScholarshipsAmt
End Year Balance	$27,740,161	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$17,114,411	BeginningYearBalanceAmt
Contributions	$2,133,374	ContributionsAmt
Investment Earnings Or Losses	-$974,377	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$711,653	GrantsOrScholarshipsAmt
End Year Balance	$17,561,755	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$10,363,214	BeginningYearBalanceAmt
Contributions	$6,170,675	ContributionsAmt
Investment Earnings Or Losses	$1,125,396	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$544,874	GrantsOrScholarshipsAmt
End Year Balance	$17,114,411	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	1.00000	PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd
Total Book Value Land Buildings	$0	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	DUE TO ASCO	Desc
Amt	$1,419,496	Amt

Field	Value	IRS element (for citing)
Total Liability	$1,419,496	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$29,234,565	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$4,592,640	NetUnrealizedGainsInvstAmt
Revenue Not Reported	$4,592,640	RevenueNotReportedAmt
Revenue Subtotal	$24,641,925	RevenueSubtotalAmt
Investment Expenses Not Incld	$35,258	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$35,881	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	-$623	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$24,641,302	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$28,406,179	TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported	$0	ExpensesNotReportedAmt
Expenses Subtotal	$28,406,179	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$35,258	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	-$35,881	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	-$623	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$28,405,556	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART V, LINE 4:	PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS.
PART X, LINE 2:	CONQUER CANCER IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC"). IT HAS BEEN GRANTED PUBLIC CHARITY STATUS BY THE INTERNAL REVENUE SERVICE (THE "IRS") AND HAS BEEN CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. IN 2021, CONQUER CANCER GENERATED NO UNRELATED BUSINESS INCOME. IN 2020, CONQUER CANCER GENERATED UNRELATED BUSINESS INCOME FROM ADVERTISING SOLD IN CONJUNCTION WITH THE SOCIETY'S ANNUAL MEETING. UNRELATED BUSINESS INCOME TAX OF $0 AND $170,363 WAS RECOGNIZED IN THE FINANCIAL STATEMENTS, IN 2021 AND 2020 RESPECTIVELY. CONQUER CANCER ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). CONQUER CANCER BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. GENERALLY, CONQUER CANCER IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2018.
PART XI, LINE 4B - OTHER ADJUSTMENTS:	FUNDRAISING EXPENSE -35,881.
PART XII, LINE 4B - OTHER ADJUSTMENTS:	FUNDRAISING EXPENSE -35,881.
PART V, LINES 1A-AG	ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND)	PROGRAM SERVICES	AWARDS & GRANTS	$313,000
NORTH AMERICA	PROGRAM SERVICES	AWARDS & GRANTS	$256,000
MIDDLE EAST AND NORTH AFRICA	PROGRAM SERVICES	AWARDS & GRANTS	$202,000
SOUTH ASIA	PROGRAM SERVICES	AWARDS & GRANTS	$141,000
SUB-SAHARAN AFRICA	PROGRAM SERVICES	AWARDS & GRANTS	$110,000
SOUTH AMERICA	PROGRAM SERVICES	AWARDS & GRANTS	$70,000
EAST ASIA AND THE PACIFIC	PROGRAM SERVICES	AWARDS & GRANTS	$11,000

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$1,103,000	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$1,103,000	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (18 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt
EUROPE (INCLUDING ICELAND & GREENLAND)	YOUNG INVESTIGATOR	$50,000	WIRE	$0
EUROPE (INCLUDING ICELAND & GREENLAND)	CAREER PATHWAY	$230,000	WIRE	$0
MIDDLE EAST AND NORTH AFRICA	CAREER DEVELOPMENT	$200,000	WIRE	$0
NORTH AMERICA	YOUNG INVESTIGATOR	$50,000	WIRE	$0
NORTH AMERICA	YOUNG INVESTIGATOR	$100,000	WIRE	$0
NORTH AMERICA	YOUNG INVESTIGATOR	$50,000	WIRE	$0
NORTH AMERICA	INNOVATION GRANT	$20,000	WIRE	$0
NORTH AMERICA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH AMERICA	YOUNG INVESTIGATOR	$50,000	WIRE	$0
SOUTH AMERICA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH ASIA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH ASIA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH ASIA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH ASIA	INNOVATION GRANT	$20,000	WIRE	$0
SOUTH ASIA	INNOVATION GRANT	$60,000	WIRE	$0
SUB-SAHARAN AFRICA	YOUNG INVESTIGATOR	$50,000	WIRE	$0
SUB-SAHARAN AFRICA	INNOVATION GRANTS	$40,000	WIRE	$0
SUB-SAHARAN AFRICA	INNOVATION GRANT	$20,000	WIRE	$0

Field	Value	IRS element (for citing)
Total Other Org	18	TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (11 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
ANNUAL MEETING MERIT AWARD	EUROPE (INCLUDING ICELAND & GREENLAND)	26	$27,000	WIRE
ANNUAL MEETING MERIT AWARD	NORTH AMERICA	12	$12,000	WIRE
ANNUAL MEETING MERIT AWARD	EAST ASIA AND THE PACIFIC	11	$11,000	WIRE
ANNUAL MEETING MERIT AWARD	MIDDLE EAST AND NORTH AFRICA	2	$2,000	WIRE
ANNUAL MEETING MERIT AWARD	SOUTH ASIA	1	$1,000	WIRE
GASTROINTESTINAL CANCERS SYMPOSIUM MERIT AWARD	NORTH AMERICA	2	$2,000	WIRE
GASTROINTESTINAL CANCERS SYMPOSIUM MERIT AWARD	EUROPE (INCLUDING ICELAND & GREENLAND)	4	$4,000	WIRE
GENITOURINARY CANCERS SYMPOSIUM MERIT AWARD	NORTH AMERICA	1	$1,000	WIRE
GENITOURINARY CANCERS SYMPOSIUM MERIT AWARD	EUROPE (INCLUDING ICELAND & GREENLAND)	1	$1,000	WIRE
ASCO QUALITY CARE SYMPOSIUM MERIT AWARD	NORTH AMERICA	1	$1,000	WIRE
ASCO QUALITY CARE SYMPOSIUM MERIT AWARD	EUROPE (INCLUDING ICELAND & GREENLAND)	1	$1,000	WIRE

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART I, LINE 2:

CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL EARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CONQUER CANCER REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENT WITH THE APPROVED BUDGET.

PART III ACCOUNTING METHOD:

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	FAIRCOM NEW YORK	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	12 WEST 27TH ST 13TH FLOOR	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	10001	ZIPCd

Field	Value	IRS element (for citing)
Activity	ONLINE ADVERTISING	ActivityTxt
Fundraiser Control Of Funds	0	FundraiserControlOfFundsInd
Gross Receipts	$653,743	GrossReceiptsAmt
Retained By Contractor	$60,000	RetainedByContractorAmt
Net To Organization	$593,743	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Gross Receipts	$653,743	TotalGrossReceiptsAmt
Total Retained By Contractors	$60,000	TotalRetainedByContractorsAmt
Total Net To Organization	$593,743	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	CONQUER CANCER DINNER- AM	Event1Nm
Gross Receipts Event1	$1,124,242	GrossReceiptsEvent1Amt
Charitable Contri Event1	$1,124,242	CharitableContriEvent1Amt
Entertainment Event1	$4,719	EntertainmentEvent1Amt
Other Direct Expenses Event1	$14,372	OtherDirectExpensesEvent1Amt
Event2	WWC MAR SALON	Event2Nm
Gross Receipts Event2	$103,410	GrossReceiptsEvent2Amt
Charitable Contri Event2	$103,410	CharitableContriEvent2Amt
Other Direct Expenses Event2	$3,060	OtherDirectExpensesEvent2Amt
Other Events Total	6	OtherEventsTotalCnt
Gross Receipts Other Events	$577,004	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$577,004	CharitableContriOtherEventsAmt
Oth Direct Expnss Other Events	$10,870	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$1,804,656	GrossReceiptsTotalAmt
Charitable Contributions Tot	$1,804,656	CharitableContributionsTotAmt
Entertainment Total Events	$4,719	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$28,302	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$33,021	DirectExpenseSummaryEventsAmt
Net Income Summary	-$33,021	NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	FormAndLineReferenceDesc
Explanation	FAIRCOM NY- CONQUER CANCER PAYS A RETAINER FEE FOR FUNDRAISING SERVICES, INCLUDING STRATEGY, COPY WRITING, LIST RECOMMENDATIONS, DATA ANALYSIS, ETC.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (50 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLACE BOX 1075	NEW YORK	NY	10029	136171197	501(C)(3)	$250,000	$0	CDA, GO YIA
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DR STE 2200 CB 1350	CHAPEL HILL	NC	275991350	566001393	GOVT ENTITY	$850,000	$0	ACRA, CDA, YIA
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
1200 CHILDRENS AVENUE	OKLAHOMA CITY	OK	73104	731563627	GOVT ENTITY	$50,000	$0	YIA
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
12902 MAGNOLIA DRIVE	TAMPA	FL	33612	592451713	501(C)(3)	$30,000	$0	ASCO REGISTRY RESEARCH GRANT
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVE	BRONX	NY	10461	830621846	501(C)(3)	$50,000	$0	GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENUE	NEW YORK	NY	10065	131623978	501(C)(3)	$100,000	$0	YIA
UNIVERSITY OF COLORADO
13001 E 17TH PLACE ROOM W1124	AURORA	CO	80045	846000555	GOVT ENTITY	$102,000	$0	YIA, MEDICAL STUDENT ROTATION MENTORSHIP
UNIVERSITY OF MIAMI
1320 S DIXIE HIGHWAY	CORAL GABLES	FL	33146	590624458	501(C)(3)	$200,000	$0	CDA
CITY OF HOPE
1500 EAST DUARTE ROAD	DUARTE	CA	910103000	953432210	501(C)(3)	$50,000	$0	YIA
MD ANDERSON SERVICES CORPORATION
1515 HOLCOMBE BOULEVARD	HOUSTON	TX	770304009	760300816	501(C)(3)	$300,000	$0	YIA
EMORY UNIVERSITY
1599 CLIFTON ROAD 4TH FLOOR	ATLANTA	GA	30322	580566256	501(C)(3)	$200,000	$0	CDA
UNIVERSITY OF CALIFORNIA IRVINE
160 ALDRICH HALL	IRVINE	CA	926977600	952226406	GOVT ENTITY	$50,000	$0	YIA
UNIVERSITY OF CALIFORNIA DAVIS
1850 RESEARCH PARK DRIVE	DAVIS	CA	956186153	946036494	GOVT ENTITY	$200,000	$0	CDA
SEATTLE CHILDREN'S HOSPITAL
1900 NINTH AVENUE M/S 818-S	SEATTLE	WA	981011309	910564748	501(C)(3)	$250,000	$0	CDA, YIA
MAYO CLINIC
200 FIRST STREET SW	ROCHESTER	MN	559050001	416011702	501(C)(3)	$500,000	$0	CDA, YIA
UNIVERSITY OF WISCONSIN
21 N PARK ST SUITE 6401	MADISON	WI	537151218	396006492	GOVT ENTITY	$100,000	$0	YIA
DUKE UNIVERSITY
2200 W MAIN ST STE 820	DURHAM	NC	27705	560532129	501(C)(3)	$452,000	$0	MSR, ACRA
AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC
2318 MILL RD STE 800	ALEXANDRIA	VA	22314	136180380	501(C)(3)	$7,797,511	$0	SUPPORT FOR: PROFESSIONAL DEVELOPMENT; EDUCATION, EQUITY, DIVERSITY & INCLUSION PROGRAMS; RESEARCH ON COVID-19 IMPACT ON ONCOLOGY PATIENTS
YALE UNIVERSITY
25 SCIENCE PARK	NEW HAVEN	CT	06510	060646973	501(C)(3)	$150,000	$0	YIA
ST JUDE CHILDREN'S RESEARCH HOSPITAL INC
262 DANNY THOMAS PLACE	MEMPHIS	TN	38105	620646012	501(C)(3)	$250,000	$0	CDA, GO YIA
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
2716 SOUTH STREET	PHILADELPHIA	PA	19146	231352166	501(C)(3)	$100,000	$0	YIA
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET	ANN ARBOR	MO	48109	386006309	GOVT ENTITY	$368,400	$0	CAREER PATHWAY GRANT IN SYMPTON MANAGEMENT
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RD	PORTLAND	OR	97034	931176109	GOVT ENTITY	$200,000	$0	CDA
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUE	BOSTON	MA	02215	042103881	501(C)(3)	$200,000	$0	CDA
VANDERBILT UNIVERSITY MEDICAL CENTER
3319 WEST END AVENUE SUITE 970	NASHVILLE	TN	37203	352528741	501(C)(3)	$300,000	$0	CDA, YIA
RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
333 COTTMAN AVENUE	PHILADELPHIA	PA	191112434	236296135	501(C)(3)	$100,000	$0	YIA
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
3333 CALIFORNIA STREET SUITE 315	SAN FRANCISCO	CA	94143	946036493	GOVT ENTITY	$350,000	$0	CDA, YIA
UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET 5TH FL FRANKLIN	PHILADELPHIA	PA	191046205	231352685	GOVT ENTITY	$100,000	$0	YIA	BLDG
RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
35 STATE STREET	ALBANY	NY	12207	141368361	501(C)(3)	$50,000	$0	YIA
UNIVERSITY OF SOUTH FLORIDA
4019 E FOWLER AVENUE SUITE 100	TAMPA	FL	33617	593102112	GOVT ENTITY	$50,000	$0	YIA
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472	SEATTLE	WA	98195	916001537	GOVT ENTITY	$115,000	$0	CAREER PATHWAY GRANT IN SYMPTION MANAGEMENT
DANA-FARBER CANCER INSTITUTE INC
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	$600,000	$0	CDA,YIA
LELAND STANFORD JUNIOR UNIVERSITY
455 BROADWAY	REDWOOD CITY	CA	940633126	941156365	501(C)(3)	$100,000	$0	YIA
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
455 MAIN STREET	CAMBRIDGE	MA	02142	061043412	501(C)(3)	$50,000	$0	YIA
UNIVERSITY OF CINCINNATI
51 GOODMAN DR SUITE 530	CINCINNATI	OH	452210222	316000989	GOVT ENTITY	$200,000	$0	CDA
UNIVERSITY OF ROCHESTER
518 HYLAN BUILDING - BOX 270140	ROCHESTER	NY	14627	160743209	501(C)(3)	$50,000	$0	YIA
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVD	DALLAS	TX	75390	756002868	GOVT ENTITY	$50,000	$0	YIA
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVD	DALLAS	TX	753909020	756002868	GOVT ENTITY	$50,000	$0	YIA
THE GENERAL HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREET	BOSTON	MA	02114	041564655	501(C)(3)	$480,000	$0	CAREER PATHWAY GRANT IN SYMPTON MANAGEMENT, YIA
COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
630 WEST 168TH STREET BOX 49	NEW YORK	NJ	100327922	135598093	501(C)(3)	$430,000	$0	ASCO REGISTRY RESEARCH GRANT, CDA, YIA
JOHNS HOPKINS UNIVERSITY
733 N BROADWAY MRB STE 117	BALTIMORE	MD	212051832	520595110	501(C)(3)	$400,000	$0	CDA
BRIGHAM AND WOMEN'S HOSPITAL INC
75 FRANCIS STREET	BOSTON	MA	02116	042312909	501(C)(3)	$50,000	$0	YIA
NORTHWESTERN UNIVERSITY
750 N LAKE SHORE DRIVE	CHICAGO	IL	606114579	362167817	501(C)(3)	$50,000	$0	YIA
TUFTS MEDICAL CENTER
800 WASHINGTON STREET	BOSTON	MA	021111526	043400617	501(C)(3)	$50,000	$0	YIA
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVD	LOS ANGELES	CA	90048	951644600	501(C)(3)	$200,000	$0	CDA
CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUE	CLEVELAND	OH	441950001	340714585	501(C)(3)	$50,000	$0	YIA
REGENTS OF THE UNIVERSITY OF UNIVERSITY OF CALIFORNIA AT SAN DIEGO
9500 GILMAN DRIVE	LA JOLLA	CA	92093	956006144	GOVT ENTITY	$50,000	$0	YIA
WASHINGTON UNIVERSITY IN ST LOUIS
CAMPUS BOX 1054 ONE BROOKINGS DRIVE	ST LOUIS	MO	63130	430653611	501(C)(3)	$100,000	$0	YIA
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA	HOUSTON	TX	770303411	741613878	501(C)(3)	$150,000	$0	YIA
ASCO ASSOCIATION
2318 MILL RD STE 800	ALEXANDRIA	VA	22314	833561693	501(C)(6)	$6,000	$0	MEMBERSHIP ASSISTANCE

Field	Value	IRS element (for citing)
Total501c3 Org	50	Total501c3OrgCnt
Total Other Org	1	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (3 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
MERIT AWARDS	158	$160,000
MEDICAL STUDENT ROTATION AWARDS	26	$215,000
ANNUAL MEETING RESEARCH AWARDS	7	$10,500

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 2:	CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES AND SPONSORING INSTITUTIONS ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CONQUER CANCER AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT BY THE END OF THE PROJECT PERIOD OR TO MEET THE PROPOSED TIME SCHEDULES. CONQUER CANCER MAY APPROVE UP TO A MAXIMUM OF THREE NO-COST EXTENSIONS OF SIX MONTH INCREMENTS. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE THEIR SPONSORING INSTITUTION DURING THE COURSE OF THEIR GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (EXPENDITURE REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND AN EXPENDITURE REPORT ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF EACH GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, A FINAL PROGRESS REPORT AND A FINAL EXPENDITURE REPORT ARE REQUIRED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CONQUER CANCER. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROGRESS REPORT, FINAL EXPENDITURE REPORT, ANY REMAINING BALANCE ON THE GRANT, AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS OF THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.
PART I, LINE 1	CONQUER CANCER GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CONQUER CANCER'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES AND SPONSORING INSTITUTIONS ARE REQUIRED TO SIGN A GRANT AGREEMENT THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CONQUER CANCER AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT BY THE END OF THE PROJECT PERIOD OR TO MEET THE PROPOSED TIME SCHEDULES. CONQUER CANCER MAY APPROVE UP TO A MAXIMUM OF THREE NO-COST EXTENSIONS OF SIX MONTH INCREMENTS. GRANTEES ARE REQUIRED TO NOTIFY CONQUER CANCER IF THEY PLAN TO LEAVE THEIR SPONSORING INSTITUTION DURING THE COURSE OF THEIR GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO CONQUER CANCER'S REVIEW AND APPROVAL. CONQUER CANCER REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (EXPENDITURE REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND AN EXPENDITURE REPORT ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF EACH GRANT BUDGET PERIOD. CONQUER CANCER REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, A FINAL PROGRESS REPORT AND A FINAL EXPENDITURE REPORT ARE REQUIRED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CONQUER CANCER REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CONQUER CANCER. GRANTS ARE ADMINISTRATIVELY CLOSED AFTER RECEIPT OF THE FINAL PROGRESS REPORT, FINAL EXPENDITURE REPORT, ANY REMAINING BALANCE ON THE GRANT, AND AFTER CONQUER CANCER'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS OF THE GRANT HAVE BEEN MET. CONQUER CANCER RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.
PART II, COLUMN H	AWARD ABBREVIATIONS: YIA: YOUNG INVESTIGATOR AWARD GO YIA: GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD CDA: CAREER DEVELOPMENT AWARD MSR: MEDICAL STUDENT ROTATION AWARD ACRA: ADVANCED CLINICAL RESERACH AWARD

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
CLIFFORD HUDIS MD FACP FASCO
CHIEF EXECUTIVE OFFICER	$0	$886,337	$0	$1,200	$0	$1,188	$0	$21,750	$0	$0	$0	$910,475	$0	$0
NANCY DALY MS MPH
CEO & EXECUTIVE VP	$0	$413,369	$0	$1,000	$0	$1,188	$0	$21,750	$0	$24,437	$0	$461,744	$0	$0
LINDA JENSEN CPA
CFO & EXECUTIVE VP	$0	$410,000	$0	$1,200	$0	$2,351	$0	$21,750	$0	$20,809	$0	$456,110	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 3	FormAndLineReferenceDesc
Explanation	COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO). THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE.	ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	8	ContributionCnt
Noncash Contributions Rpt F990	$82,417	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FMV	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1A	AS OF DECEMBER 31, 2021, THE BOARD OF DIRECTORS OF CONQUER CANCER INCLUDED TWENTY (20) DIRECTORS WITH VOTING RIGHTS, AND TWO (2) WITHOUT VOTING RIGHTS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTENT WITH CONQUER CANCER'S BYLAWS. THE EXECUTIVE COMMITTEE IS COMPOSED OF SIX MEMBERS, WHO ARE THE CHAIR OF THE BOARD OF DIRECTORS, THE SECRETARY, THE TREASURER, THE EXECUTIVE VICE CHAIR AND THE CHIEF EXECUTIVE OFFICER (NONVOTING), AND A SIXTH DIRECTOR WHO IS NOMINATED BY THE CHAIR OF THE BOARD AND ELECTED BY A MAJORITY OF THE VOTING MEMBERS OF THE BOARD OF DIRECTORS. ALL OF THE MEMBERS OF THE EXECUTIVE COMMITTEE EXCEPT THE CHIEF EXECUTIVE OFFICER ARE ENTITLED TO VOTE. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CONQUER CANCER'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CONQUER CANCER'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 2	DR CLIFFORD HUDIS, NANCY DALY AND LINDA JENSEN ARE EMPLOYED BY ASCO. DR. HUDIS SERVED AS CHIEF EXECUTIVE OFFICER EO OF ASCO AND LINDA JENSEN SERVED AS CHIEF FINANCIAL OFFICER OF ASCO. DR. HOWARD BURRIS, III, SERVED AS CHAIR OF THE BOARD OF DIRECTORS AND PAST PRESIDENT OF ASCO.
FORM 990, PART VI, SECTION A, LINE 7A	CONQUER CANCER DOES NOT HAVE MEMBERS. DIRECTORS OF CONQUER CANCER ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.
FORM 990, PART VI, SECTION A, LINE 7B	THE BOARD OF DIRECTORS OF CONQUER CANCER MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CONQUER CANCER, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CONQUER CANCER MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE.
FORM 990, PART VI, SECTION B, LINE 11B	A COPY OF THE TAX RETURN, INCLUDING ALL APPLICABLE SCHEDULES, WAS PROVIDED TO THE BOARD OF DIRECTORS, CHIEF FINANCIAL OFFICERHI AND GENERAL COUNSEL FOR REVIEW AND COMMENT PRIOR TO ITS FILING.
FORM 990, PART VI, SECTION B, LINE 12C	CONQUER CANCER MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CONQUER CANCER STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CONQUER CANCER'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CONQUER CANCER'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CONQUER CANCER IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CONQUER CANCER DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE CHIEF EXECUTIVE OFFICER OF CONQUER CANCER, THE EXECUTIVE VICE CHAIR OF CONQUER CANCER, AND THE CHIEF FINANCIAL OFFICER OF CONQUER CANCER SERVE AS EMPLOYEES OF ASCO. INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION, INCLUDING REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CONQUER CANCER. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CONQUER CANCER DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS.
FORM 990, PART VI, SECTION C, LINE 19	CONQUER CANCER'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. CONQUER CANCER'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CONQUER CANCER'S WEBSITE. THE ANNUAL REPORT OF CONQUER CANCER IS POSTED ON CONQUER CANCER'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CONQUER CANCER UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CONQUER CANCER ARE POSTED ON CONQUER CANCER'S WEBSITE.
PART XII, LINE 2C	THE AUDIT OVERSIGHT PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Direct Controlling NADirectControllingNACd	Controlled OrganizationControlledOrganizationInd	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2318 MILL RD SUITE 800	ALEXANDRIA	VA	22314	136180380	EDUCATION	NY	501(C)(3)	LINE 10	N/A	0
ASCO ASSOCIATION
2318 MILL RD SUITE 800	ALEXANDRIA	VA	22314	833561639	MEMBER SERVICES	VA	501(C)(6)			0	ASCO
ASCO ASSOCIATION PAC
2318 MILL RD SUITE 800	ALEXANDRIA	VA	22314	844213157	PAC	VA	527			0	ASCO ASSOCIATION

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (1)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (1)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	Yes (1)	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (1)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	Yes (1)	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (1)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (1)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (1)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (1)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd